Oppenheimer Assumes Dyne Therapeutics (DYN) at Outperform (correction)
Tweet Send to a Friend
(Updated - June 2, 2025 8:52 AM EDT)
Oppenheimer analyst Jay Olson assumes Dyne Therapeutics (NASDAQ: DYN) at Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jay Olson assumes Dyne Therapeutics (NASDAQ: DYN) at Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
